Community-associated methicillin-resistant staphylococcus aureus (ca-mrsa) skin infections

Current Opinion in Pediatrics

Volumn 22, Issue 3, 2010, Pages 273-277

  Odell, Christine A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abscess; Community associated MRSA; Incision and drainage; Skin and soft tissue infection

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CEFRADINE; CHLORHEXIDINE; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PLACEBO; PSEUDOMONIC ACID;

ABSCESS; ABSCESS DRAINAGE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; CELLULITIS; CLINICAL TRIAL; COMMUNITY; DRUG EFFICACY; EMERGENCY WARD; HOSPITALIZATION; HUMAN; IMPETIGO; INCISION; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OUTPATIENT CARE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT FAILURE;

ABSCESS; ANTI-BACTERIAL AGENTS; CHILD; COMBINED MODALITY THERAPY; COMMUNITY-ACQUIRED INFECTIONS; DRAINAGE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 77952420603     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328339421b     Document Type: Review

References (49)

1. Centers for Disease Control and Prevention. Community-associated methi-cillin-resistant Staphylococcus aureus infections in Pacific Islanders: Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004; 53:767-770.
2. Herald BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J Am Med Assoc 1998;279:593-598.
3. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002; 21:910-916.
4. David MZ, Crawford SE, Boyle-Vavra S, et al. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis 2006; 631-637.
5. Whitman TJ. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dis Mon 2008; 54:780-786.
6. Una G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-1132.
7. Naimi TS, Ledell KH, Como-Sabetti K, et al. Comparison of community-and healthcare-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976-2984.
8. Deresinski S. Methicillin-resistant Staphyloccus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40:562-573.
9. Hewlett AL, Falk PS, Hughes KS, Mayhall G. Epidemiology of methicillin-susceptible Staphylococcus aureus in a university medical center day care facility. Pediatr Infect Dis J 2010;29:1-3.
10. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants: Colorado, Indiana, Pennsylvania, and Los Angeles county, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:793-779.
11. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus among players on a high school football team: New York City, 2007. MMWR Morb Mortal Wkly Rep 2009;58:52-54.
12. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352:468-475.
13. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus infections: Los Angeles County, 2002-2003. Morb Mortal Wkly Rep 2003; 52:88.
14. Cook HA, Furuya EY, Larson E, et al. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007; 44:410-413.
15. Jones TF, Creech CB, Erwin P, et al. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006;42:e76-e78.
16. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities: Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52:992-996.
17. El-Sharif A, Ashour HM. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp Biol Med 2008; 233:874-880.
18. Gilbert M, MacDonald J, Gregson D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness, or incarceration. CMAJ 2006; 175:149-154.
19. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns: Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep 2006; 55:329-332.
20. Healy CM, Hulten KG, Palazzi DL, et al. Emergence of new strains of methicillin-resistant Staphyloccus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39:1460-1466.
21. Zinderman CE. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004; 10:941-944.
22. David MZ, Glikman, Crawford SE, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197:1235-1243.
23. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-674.
24. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-1791.
25. Pickett A, Wilkinson M, Menoch M, et al. Changing incidence of methicillin-resistant Staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care 2009;25:831-834.
26. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008; 51:291-298.
27. Talan DA. MRSA: deadly super bug or just another Staph? Ann Emerg Med 2008; 51:299-302.
28. Braun LR, Craft D, Williams R, et al. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J 2005; 24:622-626.
29. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21:530-534.
30. Siberry GF, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37:1257-1260.
31. Schrenkenberger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42:2777-2779.
32. Proctor RA. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:584-593.
33. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-1406.
34. Ramirez-Schrempp D, Dorfman DH, Baker WE, Liteplo AS. Ultrasound soft tissue applications in the pediatric emergency department: to drain or not to drain? Pediatr Emerg Care 2009; 25:44-48.
35. Squire BT, Fox JC, Anderson C. ABSCESS; applied bedside sonography for convenient evaluation of superficial soft tissue infections. Acad Emerg Med 2005; 12:601-606.
36. Tayal VS, Hasan N, Norton HJ, et al. The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department. Acad Emerg Med 2006; 13:384-388.
37. Sivitz AB, Lam SH, Ramirez-Schrempp D, et al. Effect of bedside ultrasound on management of pediatric soft-tissue infection. J Emerg Med (in press).
38. Llera JL, Levy RC. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med 1985; 14:15-19.
39. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at riskfor community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007; 51:4044-4048.
40. Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med (in press).
41. Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007; 44:777-784.
42. Hyun DY, Mason EO, Forbes A, Kaplan SL. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and softtissue infections. Pediatr Infect Dis J 2009; 28:57-59.
43. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23:123-127.
44. Teng C-S, Lo W-T, Wang S-R, et al. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children. J Microbiol Immunol Infect 2009; 42:324-328.
45. Elliott DJ, Zaoutis TE, Troxel AB, et al. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin- resistant Staphylococcus aureus. Pediatrics 2009; 123:e959-e966.
46. Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003; 51:613-617.
47. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009; 935-941.
48. Bartels MD, Kristoffersen K, Boye K, Westh H. Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clin Microbiol Infect 2010; 16:78-83.
49. Miller LG, Diep BA. Colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46:752-760.